Shingo Yano, MD
Interventional Pain Medicine · New Lenox, ILNPI 1538285614
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Nalu Medical, Inc. at 52.4% of the total. Reporting peaked in 2023 at $212 and has fallen 84.3% since, to $33 in 2024. That places this record below the midpoint for interventional pain medicine clinicians in IL, where the typical reported total is $2,254.
Across 19 payments — averaging $22.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nalu Medical, Inc.$223
- Medtronic$120
- GRT US Holding, Inc.$23
- Averitas Pharma Inc.$23
- Foundation Fusion Solutions, LLC$19
- Boston Scientific$18
What the payments were for
- Food & beverage$426100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nalu Medical, Inc. | 11 | $223 |
| Medtronic(2 entities) | 4 | $120 |
| GRT US Holding, Inc. | 1 | $23 |
| Averitas Pharma Inc. | 1 | $23 |
| Foundation Fusion Solutions, LLC | 1 | $19 |
| Boston Scientific | 1 | $18 |
How this compares
$426 in reported general payments places this provider in the 20th percentile of 93 interventional pain medicine providers in Illinois.
See all interventional pain medicine providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,135 | $34,003 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 249 | $11,808 |
| Oxycodone Hcl | 96 | $3,011 |
| Gabapentin | 207 | $2,659 |
| Tramadol Hcl | 288 | $2,552 |
| Lidocaine | 33 | $2,352 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 71 | $1,076 |
| Butalb-Acetaminoph-Caff-CodeinButalbit/Acetamin/Caff/Codeine | 13 | $1,052 |
| Cyclobenzaprine Hcl | 81 | $977 |
| Tizanidine Hcl | 49 | $602 |
| Pregabalin | 42 | $551 |
| Hydromorphone Hcl | 18 | $408 |
| Baclofen | 22 | $170 |
| Celecoxib | 16 | $93 |
| Meloxicam | 57 | $75 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in New Lenox
- Alexander FeoktistovNorthfield$922K
- Timothy LubenowChicago$556K
- Sandeep AminChicago$430K
- Matthew JaycoxChicago$123K
- Hong VoChicago$91K
- Asokumar BuvanendranChicago$52K
- Ramsin BenyaminBloomington$32K
- Adam YoungChicago$29K
- Salman SagarwalaChicago$26K
- Jay JoshiDeer Park$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.